Commodities
Opus Genetics COO Sells $13,653 in Stock: What Insider Moves Signal for Biotech Investors
Opus Genetics COO Joseph Schachle has disclosed a $13,653 sale of common stock, drawing attention from traders who track insider activity as a leading sentiment signal in small-cap biotech. Here is what the transaction context, technical levels, and market correlations tell us about the stock's near-term outlook.